Caris ’ studies show use of molecular profiling to develop oncology therapies

US-based Caris Life Sciences has reported positive data from two studies conducted for the validation of its tumour molecular profiling approach to guide the development of therapeutic strategies.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news